ABSTRACT: Primary Non Hodgkin's lymphoma (NHL) of orbit is rare, representing 8-10% of extranodal NHLs and 1% of all NHLs. Of these, High grade lymphomas have an aggressive course and early propensity for systemic spread despite early aggressive treatment.We report 2 cases of Orbital NHL who presented initially with Unilateral upper lid mass, and bilateral proptosis which on further evaluation were diagnosed to have Orbital NHL with tissue biopsy showing Diffuse Large B cell lymphoma in one and mixed variety in other respectively. They were started on chemotherapy. Our first patient defaulted after 4 cycles and came later with inguinal and axillary lymphadenopathy and painful arm swellings. Second patient received 10 cycles of chemotherapy but he developed diffuse Lymphadenopathy and hepatosplenomegaly. In both the cases only palliative care could be offered.
INTRODUCTION
Orbit is an uncommon primary site for Non Hodgkin's lymphoma, accounting for less than 1% of all sites of primary presentations. [1] However, Lymphoid tumors are the most common primary orbital malignancies in adults. Majority of them are low grade lymphomas (80%) and respond well to radiotherapy. [2] High grade lymphomas are rare(16%) and are known to have a higher incidence of systemic spread. Hereby, we report two interesting cases of primary orbital non hodgkin's lymphomas with systemic spread.
CASE 1
A 54 year old male presented with complaints of swelling in Right Upper eyelid for 1 month. It was non progressive and painless. On examination, a firm, non tender mass was noted in the medial canthal region with eccentric proptosis. CT orbit showed sino-ethmoidal mass encroaching medial quadrant causing eccentric proptosis. 
CASE 2
A 50 years old male presented with complaints of bilateral protrusion of eyes for 1 year. He was a known coronary artery disease patient for 8 years. On examination, he had bilateral proptosis with bilateral submandibular lymphadenopathy. Right Incisional biopsy of submandibular nodes showed Small to medium sized B-cell lymphoma.
Fig 3-Histopathological picture
Echocardiography showed Left Ventricle Ejection Fraction -44%. So, Adriamycin was withheld for this patient due to its cardiotoxicity. He was started on COP chemotherapy (Vincristine 2mg as i.v bolus injection, Cyclophosphamide 1gm as i.v infusion over 2 hours and Prednisolone orally 40 mg BD for day1 to 5, each cycle repeated every 21 days) but he lost for follow up after 10 cycles.He presented after 6 months with Bilateral increasing proptosis. Systemic evaluation included an echocardiogram which showed Pericardial effusion ,CT chest and abdomen which showed diffuse lymphadenopathy, hepatosplenomegaly and pleural effusion. Since the patient's performance status was poor, palliative care was offered for him.
Fig 4-CT chest and abdomen
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DISCUSSION
Lymphomas of the orbit are uncommon and may involve any site in the orbit. They are common in the age group of 50 to 70 years. The clinical presentation of orbital lymphomas includes palpable mass, ptosis, proptosis and excess tearing. Staging of Non Hodgkin's lymphoma is done by Biopsy and Histopathological examination of the lesion. Systemic workup includes complete blood counts, liver and kidney function tests, peripheral blood film, bone marrow biopsy, chest X-ray, computerized tomogram (CT) of the orbit, chest and abdomen.
Treatment modalities of Primary Orbital lymphomas include Radiotherapy, Chemotherapy and Surgery. Excision with primary radiotherapy is very effective in localised lymphomas in early stages. In advanced cases, chemotherapy followed by Palliative radiotherapy is very effective than isolated chemotherapy. [4] Surgery alone is not useful except in conjunctival masses. [5] Major prognostic criteria for orbital adnexal lymphomas include anatomic location of the tumor; stage of disease at first presentation, lymphoma subtype as determined using the revised European American lymphoma (REAL) classification [6] , immunohistochemical markers and the serum lactate dehydrogenase level (LDH).
CONCLUSION
These cases are reported to emphasize the need for full staging work up for early and appropriate management of these patients. In high grade histology, follow up is mandatory at close intervals to recognise and treat early systemic spread.
